AYI enters the final stretch of April with a notable divergence: short sellers are pulling back while options traders have turned more bullish — a setup that runs against the cautious tone that dominated just two weeks ago.
The clearest shift is in options positioning. The put/call ratio has dropped to 0.72, well below its 20-day average of 0.99 and nearly one standard deviation to the bullish side. That marks a sharp reversal from mid-April, when the PCR touched 1.34 — the highest reading of the past year — as macro turbulence prompted heavy demand for downside protection. The air has cleared since then, and calls are now comfortably outpacing puts on a relative basis.
Short positioning tells the same story. Estimated short interest has fallen roughly 8% over the week to 3.2% of the free float — a level that is not extreme by any measure, and down from a local peak near mid-April when shorts briefly accumulated near 1.27 million shares. The borrow market reflects no friction: cost to borrow is a modest 0.44%, with availability very loose. That combination — low short interest, cheap borrow, ample availability — points to a market where bears are not pressing a view, rather than one under any squeeze dynamic. Days to cover stands at 1.6, meaning the position could be unwound in under two sessions.
The Street is leaning cautious but not bearish. The consensus on is a collective hold, with all three covering analysts holding neutral-to-positive ratings but no fresh upgrades in the data. Goldman Sachs cut its target to $295 from $342 on April 6 while keeping a Neutral rating; Baird trimmed to $315 from $320 on the same day. The current price of $285.11 sits below every published target, which puts analyst return potential at roughly 21% to the average — though that gap largely reflects the series of target reductions since January rather than new conviction. Wells Fargo and Morgan Stanley both hold Overweight ratings with targets in the $370–$410 range, suggesting there are still believers at the higher end. The EV/EBITDA multiple has compressed to 10.4x — down on the week and the month — making the valuation more digestible relative to where it traded in late 2025.
On the factor side, AYI stands out for one metric in particular: its 12-month forward EPS growth trajectory ranks in the 90th percentile of its universe. That momentum score is high against a backdrop where near-term EPS momentum (30-day) ranks only in the 20th percentile, suggesting the market expects the longer arc to hold even as near-term estimates have softened. One independent director, O'Shaughnessy, added 1,000 shares at $282.98 on April 8 — a modest but directionally noteworthy purchase at a price close to current levels, and the only buy-side insider activity in recent months.
The peer group has been broadly weaker this week. EMR fell 4.4% on the week and ROK dropped 2.1%, while NVT and ST eked out marginal gains. AYI's 3.8% weekly decline sits roughly in line with the more pressured names in its cohort — it has not outperformed, but it has not broken away to the downside either.
The next scheduled catalyst is Q2 results on June 23. The last print on April 2 saw the stock fall 6.5% on the day, leaving a clear benchmark for how the market has historically reacted to earnings delivery. Between now and then, the balance of options sentiment, a retreating short base, and analyst targets sitting well above spot will define how tightly the stock tracks its sector peers through a still-uncertain macro tape.
See the live data behind this article on ORTEX.
Open AYI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
